GPT2 and neoplasm: Importantly, we further demonstrated that AOA inhibited growth of PIK3CA mutant xenograft tumours by targeting GPT2, because tumours established from the two GPT2 knockdown cell pools were insensitive to AOA treatment, although they grew much slower than HCT116 PIK3CA mutant tumours expressing a control shRNA (Fig. 3b).